Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectives

Por Saunders, Nicholas A, Simpson, Fiona, Thompson, Erik W, Hill, Michelle M, Endo-Munoz, Liliana, Leggatt, Graham, Minchin, Rodney F, Guminski, Alexander
Publicado em 2012

Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis

Por Cameron, Sarina, de Long, Lilia Merida, Hazar-Rethinam, Mehlika, Topkas, Eleni, Endo-Munoz, Liliana, Cumming, Andrew, Gannon, Orla, Guminski, Alexander, Saunders, Nicholas
Publicado em 2012

Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''

Por Bowyer, Samantha, Prithviraj, Prashanth, Lorigan, Paul, Larkin, James, McArthur, Grant, Atkinson, Victoria, Millward, Michael, Khou, Muoi, Diem, Stefan, Ramanujam, Sangeetha, Kong, Ben, Liniker, Elizabeth, Guminski, Alexander, Parente, Phillip, Andrews, Miles C, Parakh, Sagun, Cebon, Jonathan, Long, Georgina V, Carlino, Matteo S, Klein, Oliver
Publicado no Br J Cancer (2017)